ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1321

A Pilot Study to Evaluate the Feasibility of Conducting Juvenile Localized Scleroderma Comparative Effectiveness Treatment Studies

Suzanne C. Li1, Kathryn S. Torok2, Mara L Becker3,4, Fatma Dedeoglu5, Polly J. Ferguson6, Robert C. Fuhlbrigge7,8, Gloria C. Higgins9, Sandy D. Hong10, Maria F. Ibarra11, Ronald Laxer12, Thomas G. Mason II13, Elena Pope14, Marilynn G. Punaro15, C. Egla Rabinovich16, Katie G. Stewart15 and Brian Feldman17, 1Pediatrics, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ, 2Pediatric Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 3Rheumatology, Children's Mercy Hospital, Kansas City, MO, 4Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, 5Rheumatology, Boston Children's Hospital, Boston, MA, 6Dept of Pediatrics--Rheum, University of Iowa Carver College of Medicine, Iowa City, IA, 7Department of Dermatology, Brigham and Women's Hospital, Boston, MA, 8Division of Immunology, Boston Children's Hospital, Boston, MA, 9Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, 10Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, 11Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, 12Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 13Rheumatology, Mayo Clinic Rochester, Rochester, MN, 14Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, 15Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, 16Pediatric Rheumatology, Duke Univ Med Ctr, Durham, NC, 17Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Morphea, Pediatric rheumatology, scleroderma and treatment

  • Tweet
  • Email
  • Print
Session Information

Session Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)

Session Type: Abstract Submissions (ACR)

Background/Purpose   Juvenile localized scleroderma (jLS) often causes severe morbidity in the developing child, including growth defects and disfigurement. Optimal therapy is not known.  The LS Children’s Arthritis and Rheumatology Research Alliance (CARRA) subgroup has been working towards improving long-term outcome for these patients. Towards this end, we have developed standardized treatment regimens based upon best available evidence and consensus methodology (consensus treatment plans, CTPs), and clinical tools to use in comparative effectiveness treatment studies. We are currently conducting a pilot study to evaluate the feasibility of conducting jLS comparative effectiveness treatment studies. Additional analyses will include evaluating performance characteristics of developed tools.

Methods Fifteen physicians from 10 CARRA centers have been conducting a prospective observational cohort study of jLS subjects initiating systemic immunosuppressive treatment. Inclusion criteria include diagnosis of jLS by pediatric rheumatologist or dermatologist, and presence of active disease according to delineated activity criteria generated by the group. Exclusion criteria include treatment with methotrexate (MTX) within prior 3 months or corticosteroids (CS) within prior 2 weeks. Subjects were treated with one of three MTX-based CTPs (MTX alone, MTX with intravenous CS (IV CS), or MTX with oral CS), determined by treating physician, and evaluated at 6 visits over 1 year.  At the start of the study, a workshop meeting was held to standardize evaluation. 

Results

The target enrollment (50 subjects) was reached. All sites enrolled subjects, with enrollment taking approximately 23 months to complete following study initiation at the first site. Subjects were enrolled in all 3 CTPs, with half enrolled in MTX + IV CS CTP. Over 40% of subjects deviated from their initial treatment regimen, with persistent activity a frequent reason. Over 80% of subjects agreed to participate in the optional sample collection and banking sub study.

Study Subject Features

 

Gender

35 Females (73%)

Age at study entry, median (range)

12.7 yr (3 – 21 yr)

Race

43 White

1 Black

2 Asian

2 unknown

 

Ethnicity

39 non-Hispanic: 9 Hispanics

Treatment Regimen

MTX alone

MTX+intravenous CS

MTX + oral CS

12 (25.5%)

24 (51%)

11 (23%)

Number who deviated from starting CTP among subjects who completed at least 2 study visits

15/34 (44%)

Agreed to participate in sample collection

38/46 (82%)

Completed 1 year of study visits

13 (26%)

Dropped out from study

2 (4%)

Conclusion

This is the first study to explore the feasibility of conducting comparative effectiveness treatment studies in jLS.  We achieved our target enrollment of 50 subjects, with subjects enrolled in all 3 standardized treatment regimens. Biological samples have been collected from the majority of subjects, which will enable future translational studies.  This study will enable us to evaluate and refine clinical tools needed for treatment studies based upon study data, and identify issues related to conducting jLS treatment studies. Further analyses of these data once completed will also include clinical effectiveness and tolerability of the 3 different treatment regimens in LS subjects.


Disclosure:

S. C. Li,
None;

K. S. Torok,
None;

M. L. Becker,
None;

F. Dedeoglu,
None;

P. J. Ferguson,
None;

R. C. Fuhlbrigge,
None;

G. C. Higgins,
None;

S. D. Hong,
None;

M. F. Ibarra,
None;

R. Laxer,
None;

T. G. Mason II,
None;

E. Pope,
None;

M. G. Punaro,
None;

C. E. Rabinovich,
None;

K. G. Stewart,
None;

B. Feldman,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-pilot-study-to-evaluate-the-feasibility-of-conducting-juvenile-localized-scleroderma-comparative-effectiveness-treatment-studies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies